Inhalation Sciences receives service orders from recurring global pharma customers
Inhalation Sciences Sweden AB (ISAB) has received service orders totaling EUR 45,000 (approximately SEK 500,000) from two long-standing pharmaceutical customers - a global pharmaceutical company and a leading global generics manufacturer.
The orders relate to service of existing PreciseInhale® instruments and reflect the continued use of ISAB's technology by established customers.
Both customers have worked with ISAB for many years, demonstrating the long-term customer relationships and recurring service opportunities associated with the company's installed instrument base.
Pontus Nobréus, CEO of Inhalation Sciences, comments:
"It's a strong signal of trust when established global customers keep coming back to us for their inhalation research needs. These orders reflect the reliability and scientific rigor of our technology, and we are committed to continuing to deliver the quality our customers depend on."
For more information, please contact:
Pontus Nobréus, CEO
Email: Pontus.Nobreus@inhalation.se
Phone: +46 72-224 20 07
About Inhalation Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ.) is a Swedish contract research organization (CRO) specializing in preclinical research and development within inhaled drugs. With our patented technology platform, PreciseInhale®, we deliver unique, high-resolution and predictive data early in the development process. This enables our clients to optimize decision-making, reduce risk, and accelerate their development projects.